Treatment of FLT3-ITD-Positive Acute Myeloid Leukemia Relapsing after Allogeneic Stem Cell Transplantation with Sorafenib

Patients with acute myeloid leukemia (AML) and internal tandem duplication of FMS-like tyrosine kinase receptor-3 gene (FLT3-ITD) mutation have poor prognoses and are often treated with allogeneic hematopoietic stem cell transplantation (HSCT). Sorafenib, an inhibitor of multiple kinases including F...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Sharma, Manish, Ravandi, Farhad, Bayraktar, Ulas Darda, Chiattone, Alexandre, Bashir, Qaiser, Giralt, Sergio, Chen, Julianne, Qazilbash, Muzaffar, Kebriaei, Partow, Konopleva, Marina, Andreeff, Michael, Cortes, Jorge, McCue, Deborah, Kantarjian, Hagop, Champlin, Richard E., de Lima, Marcos
Médium: Artigo
Jazyk:Inglês
Vydáno: 2011
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4061979/
https://ncbi.nlm.nih.gov/pubmed/21767516
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2011.07.011
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky